- Investing Ideas
- Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Japanese Pharmaceuticals & Biotech Healthy potentially undervalued
Results
12
Companies which are potentially undervalued and in an acceptable financial position.
12 companies
Kissei Pharmaceutical
Market Cap: JP¥161.7b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,990.00
7D
3.0%
1Y
-3.4%
Otsuka Holdings
Market Cap: JP¥5.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,825.00
7D
5.9%
1Y
54.4%
Sumitomo Pharma
Market Cap: JP¥671.3b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,523.00
7D
11.9%
1Y
57.2%
Astellas Pharma
Market Cap: JP¥3.8t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,181.00
7D
3.5%
1Y
60.9%
Santen Pharmaceutical
Market Cap: JP¥605.4b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,889.50
7D
-2.4%
1Y
12.4%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,271.50
7D
1.5%
1Y
45.2%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,845.50
7D
2.7%
1Y
14.5%
Chugai Pharmaceutical
Market Cap: JP¥12.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,561.00
7D
1.8%
1Y
4.9%
Daiichi Sankyo Company
Market Cap: JP¥4.7t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,695.00
7D
8.0%
1Y
-20.3%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,499.00
7D
2.9%
1Y
0.8%
Tsumura
Market Cap: JP¥276.1b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,718.00
7D
-0.7%
1Y
11.2%
PeptiDream
Market Cap: JP¥126.4b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,014.00
7D
6.6%
1Y
-38.1%